|
Cardiovascular Pharmacology
Citations 551-560 of 1154 total displayed.
|
Past content
(since Jan 1999):
|
- Special Reports
Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group
- Denis B. Buxton, Stephen C. Lee, Samuel A. Wickline, Mauro Ferrari for the Working Group Members
Circulation 2003;108:2737-2742, doi:10.1161/01.CIR.0000096493.93058.E8
[Abstract]
[Full text]
- Basic Science Reports
Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor- Agonist in Hypercholesterolemia
- Ling Tao, Hui-Rong Liu, Erhe Gao, Zhi-Ping Teng, Bernard L. Lopez, Theodore A. Christopher, Xin-Liang Ma, Ines Batinic-Haberle, Robert N. Willette, Eliot H. Ohlstein, and Tian-Li Yue
Circulation 2003;108:2805-2811; published online before print as doi:10.1161/01.CIR.0000097003.49585.5E
[Abstract]
[Full text]
- Articles
Pharmacological Modulation of Cardiac Gap Junctions to Enhance Cardiac Conduction. Evidence Supporting a Novel Target for Antiarrhythmic Therapy
- Benjamin C. Eloff, Eran Gilat, Xiaoping Wan, and David S. Rosenbaum
Circulation published December 1, 2003, doi:10.1161/01.CIR.0000101926.43759.10
[Abstract]
- Mini-Review: Expert Opinions
Should Evidence-Based Proof of Efficacy as Defined for a Specific Therapeutic Agent be Extrapolated to Encompass a Therapeutic Class of Agents?
- Elliott M. Antman and James J. Ferguson
Circulation 2003;108:2604-2607, doi:10.1161/01.CIR.0000090571.83005.CE
[Full text]
- Mini-Review: Expert Opinions
Should Evidence-Based Proof of Drug Efficacy Be Extrapolated to a "Class of Agents"?
- Curt D. Furberg and Bruce M. Psaty
Circulation 2003;108:2608-2610, doi:10.1161/01.CIR.0000090572.51900.92
[Full text]
- Mini-Review: Expert Opinions
Therapeutic Substitution: Guilty Until Proven Innocent
- Dean J. Kereiakes and James T. Willerson
Circulation 2003;108:2611-2612, doi:10.1161/01.CIR.0000103637.50536.CC
[Full text]
- Clinical Investigations and Reports
Blockade of Nucleoside Transport Is Required for Delivery of Intraarterial Adenosine Into the Interstitium: Relevance to Therapeutic Preconditioning in Humans
- Alfredo Gamboa, Andrew C. Ertl, Fernando Costa, Ginnie Farley, M. Lisa Manier, David L. Hachey, André Diedrich, and Italo Biaggioni
Circulation 2003;108:2631-2635; published online before print as doi:10.1161/01.CIR.0000101927.70100.41
[Abstract]
[Full text]
- Clinical Investigations and Reports
Water Ingestion as Prophylaxis Against Syncope
- Chih-Cherng Lu, André Diedrich, Che-Se Tung, Sachin Y. Paranjape, Paul A. Harris, Daniel W. Byrne, Jens Jordan, and David Robertson
Circulation 2003;108:2660-2665; published online before print as doi:10.1161/01.CIR.0000101966.24899.CB
[Abstract]
[Full text]
- Articles
Water Ingestion as Prophylaxis Against Syncope
- Chih-Cherng Lu, André Diedrich, Che-Se Tung, Sachin Y. Paranjape, Paul A. Harris, Daniel W. Byrne, Jens Jordan, and David Robertson
Circulation published November 17, 2003, doi:10.1161/01.CIR.0000101966.24899.CB
[Abstract]
- Articles
Blockade of Nucleoside Transport Is Required for Delivery of Intraarterial Adenosine Into the Interstitium. Relevance to Therapeutic Preconditioning in Humans
- Alfredo Gamboa, Andrew C. Ertl, Fernando Costa, Ginnie Farley, M. Lisa Manier, David L. Hachey, André Diedrich, and Italo Biaggioni
Circulation published November 17, 2003, doi:10.1161/01.CIR.0000101927.70100.41
[Abstract]
|
|
